SCM
CELG

Suvretta Capital Management’s Celgene Corp CELG Stock Holding History

Suvretta Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-367,433
Closed -$36.2M – 46
2016
Q2 		$36.2M Buy
+367,433
New +$38M 1.38% 18

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Suvretta Capital Management's CELG Position: Q3 2016 in Review

Suvretta Capital Management sold out of Celgene Corp (CELG) in Q3 2016, closing a stake of 367,433 shares — an estimated $36.2M sold.

Suvretta Capital Management first reported a position in CELG in Q2 2016 and held it in 1 quarter. The position peaked at $36.2M in Q2 2016. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Suvretta Capital Management reported no remaining Celgene Corp position as of Q3 2016 after selling out during the quarter.
  • Suvretta Capital Management sold 367,433 Celgene Corp shares in Q3 2016, an estimated $36.2M.
  • Suvretta Capital Management first reported a position in Celgene Corp in Q2 2016 and held it in 1 quarter.
  • Suvretta Capital Management's Celgene Corp position peaked at $36.2M in Q2 2016.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Suvretta Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.